共查询到19条相似文献,搜索用时 78 毫秒
1.
目的探讨肛外手工吻合技术在腹腔镜低位直肠癌保肛术中的应用价值。方法应用超声刀在腹腔镜下对15例低位直肠癌患者实施全直肠系膜切除原则的根治性手术,用肛外手工吻合的方式完成超低位结肠-直肠/肛管吻合术。结果15例患者手术经过均顺利,无中转开腹。术后发生吻合口瘘1例,无腹腔出血、感染、吻合口狭窄等并发症。手术时间125~270min,平均156min。术中出血30~180ml,平均70ml。住院时间9~14d,平均11d。15例术后随访2~37个月,平均14个月。术后局部无复发,远处肝转移1例。结论低位直肠癌行腹腔镜下超低位切除、肛外手工吻合保肛术是一种安全、经济、创伤小、疗效可靠的术式。 相似文献
2.
为探讨支撑吻合管吻合法用于低位直肠癌保肛手术的效果,本研究将102例肿瘤下缘距肛缘4~6cm的低位直肠癌拟行保肛手术者随机分为治疗组和对照组,各51例,治疗组术中采用支撑吻合管吻合法吻合肠管,对照组采用管状吻合器吻合法吻合肠管,对比两组患者术后吻合口漏及肛门坠胀不适发生率。结果显示,治疗组术后无一例发生吻合口漏;对照组发生吻合口漏5例(9.8%),其中1例经保守治疗后症状缓解,4例行吻合口漏修补术。治疗组术后吻合口漏发生率明显低于对照组,P〈0.05。术后随访,治疗组患者诉肛门坠胀不适6例(11.8%),对照组15例(29.4%),两组比较差异亦有统计学意义,P〈0.05。结果表明,支撑吻合管吻合法可有效降低低位直肠癌保肛手术后吻合口漏的发生率,且可减轻患者肛门坠胀不适症状,值得临床推广应用。 相似文献
3.
目的 探讨支撑吻合管在低位直肠癌全直肠系膜切除(TME)基础上行结肠一直肠/肛管吻合的应用.方法 155例低位直肠癌TME术后,应用支撑吻合管经肛门行结肠一直肠/肛管吻合进行消化道重建.结果 本组155例无手术死亡及术中严重并发症,术中病理检查无残端癌;术后肛周盆腔感染2例(1.29%),吻合口漏3例(1.94%),吻合13出血5例(3.23%),吻合口狭窄4例(2.58%).寿命表法计算5年生存率和局部复发率分别为78.06%(121/155)及6.45%(10/155).手术后3个月排便功能的优良率为82.58%.结论 低位直肠癌TME术后应用支撑吻合管行结肠-直肠/肛管吻合是安全可行的. 相似文献
4.
目的 探讨肛外手工吻合技术在腹腔镜低位直肠癌保肛术中的应用价值.方法 应用超声刀在腹腔镜下对15例低位直肠癌患者实施全直肠系膜切除原则的根治性手术,用肛外手工吻合的方式完成超低位结肠-直肠/肛管吻合术.结果 15例患者手术经过均顺利,无中转开腹.术后发生吻合口瘘1例,无腹腔出血、感染、吻合口狭窄等并发症.手术时间125~270 min,平均156 min.术中出血30~180 ml,平均70 ml.住院时间9~14 d,平均11 d.15例术后随访2~37个月,平均14个月.术后局部无复发,远处肝转移1例.结论 低位直肠癌行腹腔镜下超低位切除、肛外手工吻合保肛术是一种安全、经济、创伤小、疗效可靠的术式. 相似文献
5.
目的探讨双器械吻合技术联合全直肠系膜切除在低位直肠癌保肛手术中的应用方法和临床疗效。方法在全直肠系膜切除的基础上,应用双器械吻合技术,对103例低位直肠癌行低位或超低位吻合,随访3年,回顾性分析其根治性、术后排便功能、手术并发症、局部复发率。结果中低位吻合31例,超低位吻合72例;无切端癌残留,无大便失禁,无吻合口漏;全组无手术死亡;肿瘤局部复发率5.8%(6/103)。结论在全直肠系膜切除基础上,利用双器械吻合技术行低位直肠癌保肛手术是保持排便功能,减少并发症,减少局部复发,提高生活质量的有效方法。 相似文献
6.
目的 评价腹腔镜全直肠系膜切除(TME)保肛术治疗中低位直肠癌的可行性、安全性和治疗效果.方法 回顾性分析2008年2月-2010年6月由同一组手术医师完成的37例腹腔镜TME与45例开腹手术保肛治疗中低位直肠癌患者的临床资料,比较两组的手术情况、并发症及近期疗效.结果 腹腔镜组术中失血量(60.6±20.9) mL、术后肠功能恢复时间(3.3±0.6)d、住院时间(9.2±2.8)d、吻合口瘘等并发症发病率(8.1%)均小于开腹组,差异有统计学意义(P<0.05).腹腔镜组和开腹组肿瘤下切缘长度(5.1±2.3vs4.3±2.0)cm、淋巴结清扫数(14.5±7.1vs15.1±5.6)枚,差异无统计学意义(P>0.05),腹腔镜组和开腹组保肛率分别为(91.9% vs 73.3%),差异具有统计学意义(P<0.05).术后随访6 ~ 36个月,腹腔镜组和开腹组患者复发率和总生存率分别是10.8%和11.1%、94.6%和91.1%,差异均无统计学意义(P>0.05).结论 腹腔镜TME保肛手术治疗中低位直肠癌是一种安全的术式,肿瘤根治效果与开腹手术相当,且提高了保肛率,并发症的发病率低,术后恢复情况优于开腹手术,值得临床推广应用. 相似文献
7.
低位直肠癌腹腔镜辅助下经肛门拖出式吻合保肛术的临床研究 总被引:1,自引:0,他引:1
目的探讨腹腔镜经肛门拖出式吻合保肛术治疗低位直肠癌的可行性、安全性、根治性及近期临床疗效。方法回顾性分析我院2002年1月-2006年12月行低位直肠癌根治术65例的临床资料。其中,行腹腔镜低位直肠癌拖出式吻合保肛术28例(腹腔镜组),直肠癌低位前切除术37例(开腹组)。分析比较两组的手术方式、手术学指标、肿瘤学指标和近期疗效。结果腹腔镜组中转开腹1例。两组在手术时间、切除标本长度、清扫淋巴结数量、肠管远切缘长度方面无显著性差异(P〉0.05)。腹腔镜组术中平均出血量少、肠道功能恢复快,显著优于开腹组(P〈0.05)。两组平均随访35个月。腹腔镜组和开腹组术后并发症发生率分别为5.9%和6.5%;复发率和总生存率分别为3.6%、5.4%和96.4%、94.6%,均无显著性差异(P〉0.05)。结论腹腔镜经肛门拖出式吻合保肛术治疗低位直肠癌能够严格地遵守肿瘤学根治性原则,安全、可行,并具有出血少、住院时间短等优点。 相似文献
8.
目的比较支撑吻合技术与DST双吻合技术(Double Stapling Technique,DST)行低位直肠癌保肛手术的临床效果、适应证选择及卫生经济学优劣。方法将60例肿瘤下缘距肛缘约4~6cm的低位直肠癌保肛手术患者,随机分为治疗组和对照组各30例。治疗组采用支撑吻合法,对照组采用DST双吻合技术,对两组疗效做对比。结果术后病理检测提示治疗组患者无远端肿瘤残留,对照组则有2例。肿瘤远端切除距离显示,治疗组平均为(2.81±0.35)cm,对照组平均为(1.73±0.42)cm。两组比较,具有统计学差异(P0.05)。治疗组术后两年均无吻合口复发,对照组则有4例,对照组复发率高于治疗组。治疗组术后早期排便功能较差,均能在1~3个月内改善。对照组术后排便功能正常,对照组和治疗组在近期肛门功能恢复上无统计学差异。治疗组术后无吻合口漏发生,对照组术后有3例吻合口漏,具有统计学差异(P0.05)。治疗组平均费用为(3.17±4.36)万元,明显低于对照组(4.40±4.72)万元,具有统计学差异(P0.05)。结论支撑吻合术对比DST双吻合技术用于低位直肠癌保肛患者治疗其疗效肯定,小样本临床观察近期复发率低,且制作成本低、操作方法简单,较之双吻合技术能节省1~1.5万元。在低位直肠癌患者术式选择中应根据患者经济条件、体型、骨盆宽窄、肿瘤分化程度及其侵犯肠管的周径合理选择支撑吻合技术或DST双吻合技术。 相似文献
9.
背景与目的:随着全直肠系膜切除(TME)理念、直肠远端2 cm原则的提出、吻合器械的应用、内括约肌切除术(ISR手术)等技术的发展,低位直肠癌保肛率大幅提高,但对于男性、肥胖、前列腺肥大、放化疗后、骨盆狭窄等“困难骨盆”患者,同时实现根治与保肛两个目标仍存在较大挑战。近年来“自下而上”的腹腔镜下经肛全直肠系膜切除术(TaTME)应运而生,并成为当今低位直肠癌治疗的热点,但随着手术的开展,吻合口相关并发症明显升高。因此,如何改进技术和方法成为降低TaTME术后吻合口漏的关键。本研究分析TaTME联合改良Bacon手术(经肛结肠拖出术)在低位直肠癌保肛手术中的效果及安全性。
方法:回顾性分析2016年10月—2019年3月行TaTME术的低位直肠癌患者共62例患者资料,其中32例联合行改良Bacon术(观察组),另30例行常规的结肠肛管(直肠)吻合(对照组)。比较两组患者术后的相关临床指标。
结果:两组手术时间、术中失血量、标本长度、远切缘长度、淋巴结清扫数量、环周切缘阳性率、术后进食时间、首次下床时间比较,差异无统计学意义(均P>0.05),但观察组住院时间明显长于对照组(10.33 d vs. 22.22 d,P<0.001)。两组患者性功能障碍、排尿障碍、肛周感染发生率比较,差异均无统计学意义(均P>0.05)。观察组吻合口瘘发生率明显低于对照组(0 vs. 16.7%,P=0.022);观察组发生吻合口狭窄1例(3.1%),对照组吻合口狭窄4例(13.3%),两组间差异无统计学意义(P=0.189)。术后7、12个月两组患者肛门功能徐忠法评分及Wexner失禁评分差异均无统计学意义(均P>0.05)。
结论:TaTME联合改良Bacon术发挥了两种手术的优点,既保证了肿瘤根治的远切缘和环周切缘,又减少了吻合口瘘的发生,且肛门功能不亚于直接吻合者,不足之处是住院时间延长,是低位直肠癌的一种合理的手术选择。 相似文献
10.
11.
12.
Background Laparoscopic resection has been shown to be a feasible option in patients with colorectal diseases. However, there have been
only a few studies on laparoscopic resection for rectal neoplasm. This report aimed to evaluate the early outcomes of patients
treated by laparoscopic rectal resection for neoplasm.
Methods From May 2000 to April 2003, 100 patients underwent laparoscopic resection for rectal neoplasm with mesorectal excision. Data
on the patients' demographics, operative details, and outcomes were collected prospectively. In those with successful laparoscopic
resection, comparison was made between patients with predominantly intracorporeal surgery (ICS) and those with anterior resection
performed with extracorporeal rectal transection and anastomosis following intracor-poreal bowel mobilization and vessel ligation
(IECS).
Results Sixty-six men and 34 women (median age, 69 years; range, 40–85) were included. Operations included 91 anterior resections,
eight abdominoperineal resections, and one Hartmann's procedure. Conversion was required in 15 patients and no conversion
was needed in patients treated by laparoscopic abdomino-perineal resection. One patient died 30 days after surgery because
of liver failure. Postoperative complications occurred in 31 patients. Among them, three had anastomotic leakage and all of
them could be treated conservatively. Reoperation was required in one patient with intestinal obstruction. Patients with conversion
were found to have significantly more blood loss, longer time to resume diet, a longer hospital stay, and a higher morbidity
rate when compared to those with successful laparoscopic surgery. Among those with successful laparoscopic procedures, no
difference was observed between patients with ICS (n=57) and those with IECS (n=28), except that a shorter incision and less blood loss were found in patients in the former group.
Conclusions Laparoscopic rectal resection with mesorectal dissection is feasible. The operating mortality and reoperation rates were low.
Conversion was associated with an increased morbidity rate, leading to a longer hospital stay. Laparoscopically assisted anterior
resection with rectal transection by a transverse stapler through the abdominal incision produced similar results when compared
to a procedure that was predominantly intracorporeally performed 相似文献
13.
腹腔镜中、下段直肠癌保肛根治术的临床分析 总被引:1,自引:0,他引:1
目的 :探讨在中、下段直肠癌保肛根治术中腹腔镜的应用、适应证及临床效果。方法 :用腹腔镜技术对 38例中、低位直肠癌患者行直肠全系膜切除 (totalmesorectalexcision ,TME)保肛根治术 ,并对手术操作、并发症的出现及术后恢复等进行临床分析。结果 :38例患者用腹腔镜技术完成手术 ,保肛率 10 0 %。手术时间 14 5 ~32 0min ,平均 16 5min ;术中出血 2 0 ~10 0ml,平均 5 0ml;术后 2 ~3d恢复胃肠功能并下床活动 ,住院时间 5 ~16d ,平均 8d。术后 8例用了止痛剂 ,无因术后并发症死亡的病例。结论 :用腹腔镜行中、低位直肠癌保肛根治术 ,不仅可达到开腹根治术的要求 ,而且具备操作安全、微创、恢复快、保肛率高的优点。 相似文献
14.
目的:探讨手工闭合直肠远端在保肛手术中的价值.方法:比较在直肠癌保肛手术中分别应用手工闭合直肠远端与直线缝合器闭合直肠远端两组的手术时间、出血量、吻合口漏发生率、切口感染率、切缘癌残留率、平均住院费用.结果:145例手工闭合直肠远端组(A组)平均手术时间2.5 h、平均出血量58 mL(10~300 mL)、吻合口漏发生率0%(0/145)、切口感染率(1/145)、切缘癌残留率0%(0/145)、平均住院费用12376元RMB.187例直线缝合器闭合直肠远端组(B组)平均手术时间2.3 h、平均出血量56 mL(10~300 mL)、吻合口漏发生率0%(0/187)、切口感染率(1/187)、切缘癌残留率0%(0/187)、平均住院费用14859元RMB.结论:在直肠癌保肛手术中应用手工闭合直肠远端是安全的,能达到直线缝合器闭合直肠远端的效果,虽平均手术时间稍长,但明显降低了住院费用. 相似文献
15.
Mason������ֱ�����ֲ��г����е�Ӧ�� 总被引:11,自引:0,他引:11
目的 探讨中下段直肠癌局部切除的途径和方法。方法 对近10年来采用Mason手术作局部切除的30例中下段直肠癌病例进行分析。结果 Tis期癌5例,T1期癌13例,T2期癌10例,T3期癌2例。所有标本切缘经病理检查未发现癌残留。平均随访为52个月。5年存活率为93%。目前未发现癌复发病例。结论 Mason手术应作为中下段直肠癌局部切除术的首选术式。 相似文献
16.
腹腔镜下直肠癌全直肠系膜切除术 总被引:17,自引:1,他引:17
目的 探讨腹腔镜下行直肠癌全直肠系膜切除根治术的临床效果。方法 对38例直肠腺癌患者采用腹腔镜下联合应用超声刀循盆筋膜壁层和脏层的间隙行锐性游离全直肠系膜,切除一个不间断的直肠整体标本,并对全组病例随访2年余。结果 38例患者手术顺利,无中转开腹,术后排便、排气时间平均为32h,术后平均住院天数为7.5d。术后随访至今,38例患者均无腹部穿刺口种植,其中2例出现局部复发(1例伴肝转移)。38例患者均无排尿困难,6例患者有性功能减退。结论 腹腔镜下行直肠癌全直肠系膜切除术手术既能有效降低术后局部复发率和保护盆腔自主神经功能,又具有微创优点,值得临床推广。 相似文献
17.
捆扎法在低位直肠癌保肛手术结肠-直肠 /肛管吻合术中应用的评价 总被引:2,自引:0,他引:2
目的评价对低位直肠癌实施保肛手术的可行性。方法选择512例低位直肠癌患者用支撑捆扎法进行低位结肠-直肠/肛管吻合保肛手术(sphincterpreservingoperation,SPO),并与542例进行腹会阴联合切除术(abdomino-perinealresection,APR)的低位直肠癌患者比较5年生存率与局部复发率,同时分析保肛术后的排便功能。结果APR和SPO组总的5年生存率分别为65.2%和69.7%;局部复发率分别为6.7%和4.8%,两组比较,差异有显著性意义(P>0.05)。SPO组中:低位吻合术5年生存率与局部复发率分别为86.2%与1.4%;超低位吻合术分别为85.3%与2.5%;Park手术分别为68.7%与4.8%;Bacon手术分别为65.7%与6.3%;低位和超低位保肛术后排便功能优良率分别为91.5%和94.3%。结论对低位直肠癌病例进行SPO手术,从根治性和功能性上评价是可行的。 相似文献
18.
19.
Background Total mesorectal excision (TME) is the surgical gold standard treatment for middle and low third rectal carcinoma. Laparoscopy
has gradually become accepted for the treatment of colorectal malignancy after a long period of questions regarding its safety.
The purposes of this study were to examine prospectively our experience with laparoscopic TME and high rectal resections,
to evaluate the surgical outcomes and oncologic adequacy, and to discuss the role of this procedure in the treatment of rectal
cancer.
Methods Between December 1992 and December 2004, all patients who underwent elective laparoscopic sphincter preserving rectal resection
for rectal cancer were enrolled prospectively in this study. Data collection included preoperative, operative, postoperative
and oncologic results with long-term follow-up.
Results A total of 218 patients were operated on during the study period: 142 patients underwent laparoscopic TME and 76 patients
underwent anterior resection. Of the TME patients, 122 patients were operated using the double-stapling technique, and 20
patients underwent colo-anal anastomosis with hand-sewn sutures. Mean operative time was 138 min (range, 107–205), and mean
blood loss was 120 ml (range, 30–350). Conversion to open surgery occurred in 26 cases (12%). Mortality rate during the first
30 days was 1%. Anastomotic leaks were observed in 10.5% of the patients. Of these, 61.9% needed reoperation and diverting
stoma, and the rest were treated conservatively. Three patients had postoperative bleeding requiring relaparoscopy. Other
minor complications (infection and urinary retention) occurred in 9.1% of patients. Mean ambulation time and mean hospital
stay were 1.6 days (range, 1–5) and 6.4 days (range, 3–28) , respectively. Patients were followed for a mean period of 57
months. No port site metastases were observed during follow-up. The recurrence rate was 6.8 %. Overall survival rate was 67%
after 5 years and 53.5% after 10 years.
Conclusion Laparoscopic anterior resection and TME with anal sphincter preservation for rectal cancer is feasible and safe. The short-
and long-term outcomes reported in this series are comparable with those of conventional surgery. 相似文献